James Investment Research Boosted Synnex (SNX) Stake; Ekso Bionics Holdings (EKSO) Shorts Increased By 11.76%

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Logo

James Investment Research Inc increased Synnex Corporation (SNX) stake by 38.95% reported in 2018Q4 SEC filing. James Investment Research Inc acquired 6,922 shares as Synnex Corporation (SNX)’s stock rose 29.19%. The James Investment Research Inc holds 24,692 shares with $2.00 million value, up from 17,770 last quarter. Synnex Corporation now has $4.82B valuation. The stock decreased 1.03% or $0.98 during the last trading session, reaching $94.2. About 358,138 shares traded. SYNNEX Corporation (NYSE:SNX) has declined 19.55% since March 15, 2018 and is downtrending. It has underperformed by 23.92% the S&P500. Some Historical SNX News: 15/03/2018 – OKI Data Americas Selects SYNNEX Corporation as Primary Distributor for Full Line of Business and Office Printing Products and; 14/05/2018 – Nine SYNNEX Corporation Leaders Named to CRN’s Women of the Channel List with One Named to Power 100 List; 11/05/2018 – Synnex Technology Intl Corp. 1Q Net Profit NT$2.25B Vs NT$1.14B; 29/03/2018 – SYNNEX 1Q REV. $4.55B, EST. $4.47B; 29/03/2018 – Synnex Gives Downbeat Quarterly Forecast — Market Mover; 08/05/2018 – World’s Best – Concentrix is First Company to Earn 20 Certifications from COPC Inc; 29/03/2018 – SYNNEX CORP – QTRLY ADJ SHR $2.14; 29/03/2018 – Synnex Sees 2Q Net $71.9M-Net $75.7M; 15/03/2018 – OKI Data Americas Selects SYNNEX Corporation as Primary Distributor for Full Line of Business and Office Printing Products and Solutions; 20/03/2018 – SYNNEX Corporation Adds Microsoft Azure IoT Solutions to Offerings

Ekso Bionics Holdings Inc (NASDAQ:EKSO) had an increase of 11.76% in short interest. EKSO’s SI was 1.85 million shares in March as released by FINRA. Its up 11.76% from 1.66M shares previously. With 586,300 avg volume, 3 days are for Ekso Bionics Holdings Inc (NASDAQ:EKSO)’s short sellers to cover EKSO’s short positions. The stock increased 0.88% or $0.02 during the last trading session, reaching $2.3. About 201,403 shares traded. Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) has risen 47.44% since March 15, 2018 and is uptrending. It has outperformed by 43.07% the S&P500. Some Historical EKSO News: 12/03/2018 – EKSO BIONICS SAYS CHARLES LI TO JOIN BOARD; 20/04/2018 – A wearable robot, the Ekso Vest, gives factory workers ant-like strength and help with overhead tasks; 13/03/2018 – Robbins Arroyo LLP: Ekso Bionics Holdings, Inc. (EKSO) Misled Shareholders According to a Recently Filed Class Action; 13/03/2018 – EKSO BIONICS HOLDINGS INC – CASH ON HAND AT DECEMBER 31, 2017 WAS $27.8 MLN, COMPARED TO $16.8 MLN AT DECEMBER 31, 2016; 27/03/2018 – National Stroke Association and Ekso Bionics® Announce Educational Partnership to Advance Stroke Rehabilitation with Exoskeleton Technology; 20/04/2018 – Ford is among the early users of the Ekso Vest, and is trying out the product in two of its U.S. plants; 09/03/2018 Ekso Bionics Holdings Short-Interest Ratio Rises 90% to 18 Days; 29/03/2018 – Ekso Bionics Holdings at Field Trip Hosted By SunTrust Today; 26/04/2018 – Global Robotic Exoskeleton Market Forecast to 2022: Expected to Grow at a CAGR of 30.38% with Cyberdyne, Ekso Bionics, Parker Hannifin, ReWalk Robotics, Rex Bionics Dominating – ResearchAndMarkets.com; 12/03/2018 – EKSO SAYS THOMAS LOOBY LEAVING CO. TO PURSUE OTHER INTERESTS

More notable recent Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) news were published by: Nasdaq.com which released: “Ekso Bionics Reports Fourth Quarter and Year End 2018 Results – Nasdaq” on February 28, 2019, also Seekingalpha.com with their article: “Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” published on February 28, 2019, Nasdaq.com published: “Worldwide Adoption of Ekso Bionics® EksoGTâ„¢ Exoskeleton Allows Stroke and Spinal Cord Injury Patients to Take 100 Million Steps to Date – Nasdaq” on December 04, 2018. More interesting news about Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) were released by: Seekingalpha.com and their article: “Ekso Bionics down 6% premarket on preliminary 2018 results – Seeking Alpha” published on January 08, 2019 as well as Nasdaq.com‘s news article titled: “Ekso Bionics® to Report Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019 – Nasdaq” with publication date: February 21, 2019.

Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa. The company has market cap of $147.79 million. The firm operates through Medical Devices, Industrial Sales, and Engineering Services divisions. It currently has negative earnings. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness.

More notable recent SYNNEX Corporation (NYSE:SNX) news were published by: Prnewswire.com which released: “SYNNEX Corporation Named 2018 Check Point North American Distributor of the Year – PRNewswire” on March 08, 2019, also Prnewswire.com with their article: “SYNNEX Corporation Announces 11 Executives Named to CRN Channel Chiefs – PRNewswire” published on March 07, 2019, Globenewswire.com published: “Recent Analysis Shows Lattice Semiconductor, ZIOPHARM Oncology, Ferro, SYNNEX, AxoGen, and Twin Disc Market Influences — Renewed Outlook, Key Drivers of Growth – GlobeNewswire” on February 14, 2019. More interesting news about SYNNEX Corporation (NYSE:SNX) were released by: Gurufocus.com and their article: “Sarah Ketterer’s Top 5 Buys for the 4th Quarter – GuruFocus.com” published on February 15, 2019 as well as Bizjournals.com‘s news article titled: “Former Convergys CEO joins board of AI-based services firm – Cincinnati Business Courier” with publication date: February 22, 2019.

Since October 1, 2018, it had 8 insider buys, and 9 selling transactions for $38.08 million activity. $9.56M worth of stock was bought by MIAU MATTHEW on Friday, October 19. SILVER STAR DEVELOPMENTS LTD had bought 6,900 shares worth $538,710. Zulberti Andrea M had sold 2,416 shares worth $218,531. Witt Marshall sold $49,278 worth of stock. MURAI KEVIN M also sold $256,203 worth of SYNNEX Corporation (NYSE:SNX) on Friday, October 26. POLK DENNIS had sold 2,000 shares worth $169,611. 2,869 SYNNEX Corporation (NYSE:SNX) shares with value of $232,864 were sold by STEFFENSEN DWIGHT.

Among 3 analysts covering Synnex (NYSE:SNX), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Synnex had 3 analyst reports since October 4, 2018 according to SRatingsIntel. Cross Research upgraded the shares of SNX in report on Friday, January 11 to “Buy” rating. The rating was upgraded by Citigroup to “Buy” on Monday, January 28. Stifel Nicolaus maintained it with “Buy” rating and $114 target in Thursday, October 4 report.

Investors sentiment increased to 2.4 in Q4 2018. Its up 1.11, from 1.29 in 2018Q3. It improved, as 40 investors sold SNX shares while 35 reduced holdings. 70 funds opened positions while 110 raised stakes. 40.03 million shares or 36.83% more from 29.26 million shares in 2018Q3 were reported. Schroder Inv Mngmt Grp Incorporated owns 0% invested in SYNNEX Corporation (NYSE:SNX) for 1,900 shares. Globeflex Cap LP accumulated 20,686 shares. 22,955 are held by Hsbc Public Limited. Goldman Sachs Gru has 0.02% invested in SYNNEX Corporation (NYSE:SNX) for 796,802 shares. Vanguard Grp Inc has invested 0.01% in SYNNEX Corporation (NYSE:SNX). Virginia Retirement Et Al stated it has 0.02% of its portfolio in SYNNEX Corporation (NYSE:SNX). New Mexico Educational Retirement Board invested 0.03% in SYNNEX Corporation (NYSE:SNX). Proshare Advisors Limited Com, Maryland-based fund reported 8,905 shares. Tompkins Financial reported 105 shares. Sei Invs Comm reported 13,212 shares. Metropolitan Life reported 0.04% of its portfolio in SYNNEX Corporation (NYSE:SNX). Moreover, Bancorporation Of Montreal Can has 0% invested in SYNNEX Corporation (NYSE:SNX) for 1,987 shares. Ameriprise Fincl holds 0.02% or 476,284 shares in its portfolio. Jacobs Levy Equity Mgmt Inc owns 19,849 shares. California-based Charles Schwab Mgmt has invested 0.02% in SYNNEX Corporation (NYSE:SNX).

James Investment Research Inc decreased Mcdermott Intl Inc stake by 294,678 shares to 3,927 valued at $25,000 in 2018Q4. It also reduced Wal (NYSE:WMT) stake by 29,431 shares and now owns 298,348 shares. Korn/Ferry International (NYSE:KFY) was reduced too.

SYNNEX Corporation (NYSE:SNX) Institutional Positions Chart